ARA-290 30 mg

ARA-290, also known as Cibinetide, is a synthetic peptide designed to selectively activate the innate repair receptor (IRR), a pathway involved in tissue protection and inflammatory regulation. Researchers have investigated ARA-290 for its potential role in supporting nerve health, reducing inflammatory signaling, and promoting the body’s natural repair processes.

Key Areas of Research

• Nerve health and neuropathy models
• Inflammatory response modulation
• Tissue-protective mechanisms
• Small fiber nerve function
• Recovery and regenerative medicine applications

What Makes ARA-290 Unique?

Unlike erythropoietin (EPO), ARA-290 was developed to target tissue-protective pathways without stimulating red blood cell production. This selective activity has made it an area of interest in studies involving chronic inflammation, nerve discomfort, and cellular recovery.

Common Research Protocols

Research protocols vary significantly depending on study objectives. In published investigations, ARA-290 has commonly been administered by subcutaneous injection, often on a daily basis for several weeks. Dosages and schedules differ across studies and should be determined according to the specific research model being utilized.

Product Details

• Peptide: ARA-290 (Cibinetide)
• Strength: 30mg
• Form: Lyophilized Powder
• Purity: Laboratory Tested
• Storage: Refrigerate after reconstitution
• Intended Use: Research Use Only

Important Notice

This product is intended exclusively for laboratory and scientific research purposes. It is not approved for human consumption, medical use, diagnosis, treatment, cure, or prevention of any disease. Researchers are responsible for complying with all applicable laws and regulations regarding the handling and use of research compounds.